Aberrant phosphorylation of human LRH1 at serine 510 is predictable of hepatocellular carcinoma recurrence
2023 · Clinical and Experimental Medicine · 3 citations
https://doi.org/10.1007/s10238-023-01098-x
K
Kotaro Sugimoto
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
90
Papers
3.0K
Citations
26
h-index
41
i10-index
Kotaro Sugimoto is an academic researcher from Fukushima Medical University. The author has contributed to research in topics: Barrier Structure and Function Studies & Cancer-related molecular mechanisms research & Cell Adhesion Molecules Research. The author has an h-index of 26, co-authored 77 publications.
ORCID: 0000-0002-5299-7610Papers by this author
worksFunctional Differences Between <scp>SIRPα</scp> Splice Isoforms
2025 · Genes to Cells · 2 citations
https://doi.org/10.1111/gtc.70041
Alloantigen-activated (AAA) CD4+ T cells reinvigorate host endogenous T cell immunity to eliminate pre-established tumors in mice
2021 · Journal of Experimental & Clinical Cancer Research · 1 citations
https://doi.org/10.1186/s13046-021-02102-6
Abnormal phosphorylation of human LRH1 at Ser510 predicts poor prognosis and promotes cell viability in lung squamous cell carcinoma
2025 · BMC Cancer · 1 citations
https://doi.org/10.1186/s12885-025-14160-6
Expression of TSLPR and IL-7Rα in epidermal keratinocytes is controlled by ΔNp63.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0105498.g001
IgSF11–RAP1 signaling promotes cell migration and invasion of cutaneous melanoma
2025 · Cell Communication and Signaling · 0 citations
https://doi.org/10.1186/s12964-025-02245-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat